Phibro Animal Health Corporation (PAHC) FY2026 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2025-07-01 to 2026-06-30

Swipe to see the full flow
Phibro Animal Health Corporation cash flow reconciliation, Jul 1, 2025 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $68,954,000.00Net income → Operating adjustments reconciliation: $30,766,000.00Depreciation and amortization → Operating adjustments reconciliation: $51,514,000.00Accrued expenses and other liabilities → Operating adjustments reconciliation: $26,351,000.00Deferred income tax expense (benefit) → Operating adjustments reconciliation: $7,226,000.00Amortization of debt issuance costs → Operating adjustments reconciliation: $2,317,000.00Acquisition-related items → Operating adjustments reconciliation: $1,956,000.00Foreign currency losses, net → Operating adjustments reconciliation: $1,633,000.00Stock-based compensation expense → Operating adjustments reconciliation: $1,597,000.00Other assets → Operating adjustments reconciliation: $1,591,000.00Operating adjustments reconciliation → Inventories, net: $86,338,000.00Operating adjustments reconciliation → Other current assets: $16,744,000.00Operating adjustments reconciliation → Accounts payable: $12,463,000.00Operating adjustments reconciliation → Accounts receivable, net: $7,493,000.00Operating adjustments reconciliation → Other: $1,913,000.00Maturities of short-term investments → investing reconciliation: $36,026,000.00investing reconciliation → Capital expenditures: $59,088,000.00investing reconciliation → Purchases of short-term investments: $47,601,000.00investing reconciliation → Other, net: $792,000.00Net cash used in financing activities → financing reconciliation: $6,560,000.00Revolving credit facility borrowings → financing reconciliation: $297,000,000.00Proceeds from insurance premium financing and other short-term debt → financing reconciliation: $8,410,000.00financing reconciliation → Revolving credit facility repayments: $268,000,000.00financing reconciliation → Dividends paid: $19,463,000.00financing reconciliation → Payments of long-term debt: $16,250,000.00financing reconciliation → Payments of insurance premium financing and other short-term debt: $7,690,000.00financing reconciliation → Debt issuance costs: $567,000.00Net cash used in investing activities → investing reconciliation: $71,455,000.00Exchange-rate effect → Cash sources and uses: $2,441,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $68,039,000.00Net cash from operating activities → Cash sources and uses: $68,954,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $61,419,000.00Cash sources and uses → Net cash used in investing activities: $71,455,000.00Cash sources and uses → Net cash used in financing activities: $6,560,000.00Net income: $99,720,000.00Net income+$99.72 MAmortization of debt issuance costs: $2,317,000.00Debt issuance cost amortization+$2.32 MDepreciation and amortization: $51,514,000.00Depreciation & amortization+$51.51 MAcquisition-related items: $1,956,000.00Acquisition-related items+$1.96 MDeferred income tax expense (benefit): $7,226,000.00Deferred taxes & credits+$7.23 MForeign currency losses, net: $1,633,000.00Unrealized FX gain & loss+$1.63 MStock-based compensation expense: $1,597,000.00Stock-based compensation+$1.60 MOther: -$1,913,000.00Other non-cash items−$1.91 MAccounts receivable, net: -$7,493,000.00Accounts receivable−$7.49 MInventories, net: -$86,338,000.00Inventories−$86.34 MOther current assets: -$16,744,000.00Prepaid & other assets−$16.74 MOther assets: $1,591,000.00Other noncurrent assets+$1.59 MAccounts payable: -$12,463,000.00Accounts payable−$12.46 MAccrued expenses and other liabilities: $26,351,000.00Accrued & other liabilities+$26.35 MNet cash from operating activities: $68,954,000.00Operating cash+$68.95 MOperating adjustments reconciliation: $124,951,000.00Revolving credit facility borrowings: $297,000,000.00Long-term credit line borrowings+$297.00 MRevolving credit facility repayments: -$268,000,000.00Long-term credit line repayments−$268.00 MPayments of long-term debt: -$16,250,000.00Other long-term debt repaid−$16.25 MDebt issuance costs: -$567,000.00Debt issuance costs−$567.00 KProceeds from insurance premium financing and other short-term debt: $8,410,000.00Premium & other debt proceeds+$8.41 MPayments of insurance premium financing and other short-term debt: -$7,690,000.00Premium & other debt repaid−$7.69 MDividends paid: -$19,463,000.00Common dividends paid−$19.46 MNet cash used in financing activities: -$6,560,000.00. Cash required to fund net payments.Financing cash−$6.56 Mfinancing reconciliation: $311,970,000.00Purchases of short-term investments: -$47,601,000.00Short-term investment purchases−$47.60 MMaturities of short-term investments: $36,026,000.00Short-term investment maturities+$36.03 MCapital expenditures: -$59,088,000.00Capital expenditures−$59.09 MOther, net: -$792,000.00Other investing, net−$792.00 KNet cash used in investing activities: -$71,455,000.00. Cash required to fund net payments.Investing cash−$71.46 Minvesting reconciliation: $107,481,000.00Cash sources and uses: $139,434,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $68,039,000.00Beginning cash$68.04 MEnding cash: Cash, cash equivalents, and restricted cash: $61,419,000.00Ending cash$61.42 MExchange-rate effect: $2,441,000.00FX effect+$2.44 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$9.87 MOperating cash − cash spent on productive assetsCash flow / Net income0.69×Operating cash flow ÷ net incomeNet cash change−$6.62 MEnding cash − beginning cash
Chart details

Phibro Animal Health Corporation cash flow reconciliation, Jul 1, 2025 through Jun 30, 2026

Cash flows for Jul 1, 2025 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Jun 30, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Jun 30, 2025
68,039,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
68,954,000 US dollars. Net cash provided.
Net income
99,720,000 US dollars
Amortization of debt issuance costs
2,317,000 US dollars
Depreciation and amortization
51,514,000 US dollars
Acquisition-related items
1,956,000 US dollars
Deferred income tax expense (benefit)
7,226,000 US dollars
Foreign currency losses, net
1,633,000 US dollars
Stock-based compensation expense
1,597,000 US dollars
Other
negative 1,913,000 US dollars
Accounts receivable, net
negative 7,493,000 US dollars
Inventories, net
negative 86,338,000 US dollars
Other current assets
negative 16,744,000 US dollars
Other assets
1,591,000 US dollars
Accounts payable
negative 12,463,000 US dollars
Accrued expenses and other liabilities
26,351,000 US dollars
Investing activities
negative 71,455,000 US dollars. Net cash used.
Purchases of short-term investments
negative 47,601,000 US dollars
Maturities of short-term investments
36,026,000 US dollars
Capital expenditures
negative 59,088,000 US dollars
Other, net
negative 792,000 US dollars
Financing activities
negative 6,560,000 US dollars. Net cash used.
Revolving credit facility borrowings
297,000,000 US dollars
Revolving credit facility repayments
negative 268,000,000 US dollars
Payments of long-term debt
negative 16,250,000 US dollars
Debt issuance costs
negative 567,000 US dollars
Proceeds from insurance premium financing and other short-term debt
8,410,000 US dollars
Payments of insurance premium financing and other short-term debt
negative 7,690,000 US dollars
Dividends paid
negative 19,463,000 US dollars
Operating adjustment reconciliation
124,951,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
311,970,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
107,481,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
2,441,000 US dollars
Ending cash on Jun 30, 2026
61,419,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
139,434,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 6,620,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
0.69×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
68,954,000 US dollars. Operating cash flow used in the free cash flow calculation.
cash spent on productive assets
59,088,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
9,866,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income exceeds operating cash. The diagram allocates $68.95M of net income directly to operating cash and $30.77M to the adjustment junction, where it combines with other additions to reconcile deductions. This is an accounting presentation, not a tracing of cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash spent on productive assets equals free cash flow: 68,954,000 US dollars minus 59,088,000 US dollars equals 9,866,000 US dollars.
Phibro Animal Health Corporation (PAHC) FY2026 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!